HF
LENZ

HRT Financial’s LENZ Therapeutics LENZ Stock Holding History

HRT Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Sell
145,506
-25,777
-15% -$362K ﹤0.01% 1883
2025
Q4 		$2.74M Buy
171,283
+141,974
+484% +$4.14M 0.01% 1105
2025
Q3 		$1.36M Buy
+29,309
New +$1.08M 0.01% 1360
2023
Q2 		– Sell
-2,785
Closed -$47K – 3419
2023
Q1 		$47K Buy
+2,785
New +$45K ﹤0.01% 2127

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

HRT Financial's LENZ Position: Q1 2026 in Review

HRT Financial reduced its LENZ Therapeutics (LENZ) stake by 15% in Q1 2026, selling an estimated $362K and leaving 145,506 shares worth $1.33M. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

HRT Financial first reported a position in LENZ in Q1 2023 and has held it in 4 quarters since. The position peaked at $2.74M in Q4 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • HRT Financial held 145,506 shares of LENZ Therapeutics worth $1.33M as of Q1 2026.
  • HRT Financial sold 25,777 LENZ Therapeutics shares in Q1 2026, an estimated $362K.
  • LENZ Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1883 holding.
  • HRT Financial first reported a position in LENZ Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • HRT Financial's LENZ Therapeutics position peaked at $2.74M in Q4 2025.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.